Companies / Accretive Health, Inc.
Accretive Health, Inc.
ACHIRCMCIK 1472595
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 1, 2021 | TCP-ASC ACHI Series LLLP Director | Sell Open-market sale | Common Stock | $316.46M | -14.5M -9.43% | 139,289,200 | high |
| May 27, 2021 | TCP-ASC ACHI Series LLLP Director | Sell Open-market sale | Common Stock | $59.21M | -2.4M -1.54% | 153,789,200 | high |
| May 27, 2021 | TCP-ASC ACHI Series LLLP Director | Exercise In-the-money exercise | Common Stock | $59.19M | +16.9M +12.14% | 156,201,846 | low |
| Jun 2, 2021 | TCP-ASC ACHI Series LLLP Director | Sell Open-market sale | Common Stock | $49.11M | -2.3M -1.59% | 139,289,200 | high |
| Jun 1, 2021 | Flanagan Joseph Gerard CEO | Sell Open-market sale | Common Stock | $10.91M | -500K -16.77% | 2,481,799 | high |
| May 28, 2021 | TCP-ASC ACHI Series LLLP Director | Exercise In-the-money exercise | Common Stock | $9.18M | +2.6M +1.88% | 141,911,699 | low |
| May 28, 2021 | TCP-ASC ACHI Series LLLP Director | Sell Open-market sale | Common Stock | $9.18M | -372K -0.26% | 141,539,200 | medium |
| Feb 17, 2022 | Flanagan Joseph Gerard CEO | Other Withheld for taxes | Common Stock | $5.78M | -224K -7.43% | 2,792,221 | low |